Roche proposes former Takeda CEO for board seat
Roche proposes former Takeda CEO for board seat ZURICH, Sept 23 (Reuters) - Roche ROPC.S on Wednesday said it was proposing Christoph Weber, the former CEO of Takeda Pharmaceuticals 4502.T, for election to the Swiss company's board of directors at its AGM next March.
"Christophe's intimate knowledge of the healthcare industry and his broad leadership experience will further strengthen our Board," said Roche Chairman Severin Schwan in a statement.
(Reporting by John Revill
Editing by Linda Pasquini)((John.Revill@thomsonreuters.com; +41 41 528 36 37; Reuters Messaging: john.revill.thomsonreuters.com@reuters.net))
Recent news on Takeda Pharmaceutical
See all newsFactbox: Pharma sector doubles down on AI to slash costs, timelines
Nvidia-backed Iambic Therapeutics tumbles below IPO price
Factbox: Pharma sector doubles down on AI to slash costs, timelines
Factbox: Pharma sector doubles down on AI to slash costs, timelines
Nvidia-backed Iambic Therapeutics launches IPO as biotechs buck market gloom (updated)